CEL-SCI Corporation (NYSE:CVM) enjoyed a 51.37% run-up in share price since hitting record low of $1.46. The stock managed 11.06% rise and now stands at $2.21 as of 01/11/2018. At recent session, the prices were hovering between $1.95 and $2.23. This company shares are 3293.67% off its target price of $75 and the current market capitalization stands at $26.41M. The recent change has given its price a 20.97% lead over SMA 50 and -51.69% deficit over its 52-week high. The stock witnessed 16.54% gains, 19.46% gains and -11.6% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CVM’s volatility during a week at 7.34% and during a month it has been found around 5.99%.CEL-SCI Corporation (CVM) Top Holders
Institutional investors currently hold around $2 million or 9.2% in CVM stock. Look at its top three institutional owners. Sabby Management, Llc owns $1.17 million in CEL-SCI Corporation, which represents roughly 4.43% of the company’s market cap and approximately 58.5% of the institutional ownership. Similar statistics are true for the second largest owner, Susquehanna International Group, Llp, which owns 143,432 shares of the stock are valued at $285 thousand. The third largest holder is Vanguard Group Inc, which currently holds $272 thousand worth of this stock and that ownership represents nearly 1.03% of its market capitalization.
At the end of 09/30/2017 reporting period, 8 institutional holders increased their position in CEL-SCI Corporation (NYSE:CVM) by some 774,638 shares, 6 decreased positions by 93,622 and 16 held positions by 178,202. That puts total institutional holdings at 1,046,462 shares, according to SEC filings. The stock grabbed 3 new institutional investments totaling 752,183 shares while 5 institutional investors sold out their entire positions totaling 93,608 shares.CEL-SCI Corporation (NYSE:CVM) Insider Trades
Multiple company employees have indulged in significant insider trading. CEL-SCI Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Chief Scientific Officer Talor Eyal has sold 769 shares of CEL-SCI Corporation (CVM) in trading session dated Aug. 25, 2017. These shares are worth $1,469 and were traded at $1.91 each. The SEC filing shows that Talor Eyal performed a sale of 14,019 shares. The Chief Scientific Officer disposed these shares by way of transaction on Aug. 16, 2017. The company’s shares were given away at $2.61 per share worth to an income of some $36,590 on account of Talor Eyal.
Senior Vice President, Cipriano John, sold 17,109 common shares of CEL-SCI Corporation (CVM) in the open market. In a transaction dated Aug. 16, 2017, the shares were put up for sale at an average price of $2.52, raking in a sum of $43,115. After this sale, 48,000 common shares of CVM are directly owned by the insider, with total stake valued at $106,080.
In the transaction dated Oct. 13, 2014, the great number of shares acquired came courtesy the CEO; Kersten Geert R added a total of 14,999 shares at an average price of $0.77, amounting to approximately $11,549. The insider now directly owns 6,659,605 shares worth $14,717,727.
Several analysts have released their opinion on CEL-SCI Corporation (NYSE:CVM), with 0 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 3 average brokerage recommendation.